Clinical Trials Browser

Phase 2 × Nasopharyngeal Carcinoma × Endoscopy × Clear all

NCT05011227 2024-03-06

Camrelizumab and Chemotherapy Combined With Endoscopic Surgery for Recurrent Nasopharyngeal Carcinoma

Phase 2 Recruiting

Nasopharyngeal Carcinoma

NCT05350891 2022-05-10

Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPC

Phase 2 Recruiting

Nasopharyngeal Carcinoma